IDO1 and major depressive disorder: IDO1 activity has been associated with decreased serotonin (5-HT) content and increased kynurenine (KYN) content and neuroplastic changes through the effect of KYN derivatives, such as quinolinic acid (QUIN), on glutamate receptors, which are all associated with depression [10,11].